Ryder Launches $50 Million Corporate Venture Capital Fund: RyderVentures
From: RegTech Analyst Private-equity firm Thoma Bravo has raised $22.8bn to three tech-focused funds, making it one of the largest fundraising hauls ever, according to the Wall Street Journal. The Chicago-based firm has previously bought
The Carlyle Group has acquired a majority stake in B2B fund network Calastone from its current shareholders, including Accel Partners and Octopus Ventures.
Private equity giant The Carlyle Group has acquired a majority stake in global funds network Calastone from Octopus Ventures and Accel.
The shares tendered in the public offer amount to 50.87 million shares, or 91% of the shareholding and voting rights in the company
US-based venture capital firm Amplify Partners has closed its fourth flagship early-stage fund Amplify Partners IV on $275m, and Amplify Select Fund, its first growth-stage vehicle, on $100m.
German private equity firm Triton Partners has acquired listed Swedish IT company HiQ International for $8.21 (SEK 72) per share.
Germany-based accommodation booking platform Limehome has expanded its series-A round to €31m, raising an additional €10m from existing investors HV Holtzbrinck Ventures, Lakestar and Picus Capital.
Apollo Global Management has sold Amissima Assicurazioni, the non-life insurance business of Italian insurer Amissima Holdings, to listed German insurance group Talanx.
From: RegTech Analyst British Patient Capital has committed to adding $35m The Evolution Technology Fund II, which is aiming for a final $250m close to support cybersecurity and enterprise software startups. The fund is the
Bixin Ventures has launched a $100m capital fund to support the global blockchain ecosystem to nurture the future of open finance.
Representatives for several public pensions say they are closely monitoring an investigation into Apollo co-founder Leon Black’s personal dealings with Epstein
Pureos Bioventures has led a CHF 15.2m seed round for Switzerland-based biotechnology company Araris Biotech.
High-Tech Gründerfonds (HTGF) and Evonik Venture Capital have sold their stakes in Finnish company Synoste to US-based medical device manufacturer Globus Medical.
